Frequently Asked Questions
The North America persistent corneal epithelial defects treatment market was USD 98.8 million in 2021.
Factors such as higher demand of hospitals and growing collaborations and partnerships are acting as the major drivers for the North America persistent corneal epithelial defects treatment market.
